• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Chatting with Rachel Haurwitz, CEO, Caribou Bio

Article

Pharmaceutical Executive

Rachel Haurwitz, CEO, Caribou Bio, discusses Caribou's technology for gene editing with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event.

Rachel Haurwitz, CEO, Caribou Bio, discusses Caribou's technology for gene editing with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event.  

Recent Videos
Related Content